Pasithea Therapeutics to host KOL event on NF1 treatment

KTTA•2026-10-28

Pasithea Therapeutics will host a virtual NF1 treatment event on November 4, 2026, at 11 a.m. ET.

1. Event details

Experts will discuss unmet needs in NF1-associated cutaneous and plexiform neurofibromas. Management will review PAS-004's Phase 1 solid tumor data and commercial opportunity in NF1.

Pasithea Therapeutics to host KOL event on NF1 treatment

1. Event details

Related News

Enerpac Tool Group Q4 adjusted EPS USD 0.53

Argentina's YPF swings to billion-dollar profit as shale boom gathers pace

Alamos Gold Q3 revenue $510.4 million

Ryerson swings to Q3 2026 net income of $32 million from year-earlier loss

Four Corners Property Trust Q3 rental revenue rises 13.8%